This is a non-core endpoint: only basic statistics are computed.
Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
2351
Check minimum number of events None
2351
Include endpoints None
2351
Remove individuals based on genotype QC
2281
R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO
Control definitions
Control exclude
R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R7
Name in latin
Ratio sedimenti erythrocytorum elevata et abnormitas viscositatis plasmatis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
based on the number of shared cases.
Broader endpoints:
- Abnormal findings on examination of blood, without diagnosis
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2281 | 1285 | 996 |
| Unadjusted prevalence (%) | 0.60 | 0.61 | 0.60 |
| Mean age at first event (years) | 63.94 | 60.38 | 68.53 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO – Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
↥Endpoint not on priority list, no data to show.